SC
Sanjay Chandan Parekh
About Sanjay Chandan Parekh
Data last updated:
Sanjay Chandan Parekh has 29 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Vestguard Security India Private Limited and Avon Lifestyle Private Limited. Formerly with 5 companies, such as Cure Medicines (India) Private Limited and Eume Lifestyle Private Limited. Engaged in General Business.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 25 Mar 1997 | 1997 | Active | |
| Designated Partner | 03 Apr 2014 | 2014 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 26 Mar 2003 | 2003 | Active | |
| Director | 10 Aug 2021 | 2021 | Active | |
| Designated Partner | 29 Jan 2014 | 2014 | Strike Off | |
| Director | 04 Aug 2016 | 2016 | Strike Off | |
| Director | 20 Jun 2007 | 2007 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sanjay Chandan Parekh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sanjay Chandan Parekh
Sanjay Chandan Parekh has 29 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Vestguard Security India Private Limited and Avon Lifestyle Private Limited. Formerly with 5 companies, such as Cure Medicines (India) Private Limited and Eume Lifestyle Private Limited. Engaged in General Business.
Sanjay Chandan Parekh is associated with 2 companies as Director and Designated Partner.
Sanjay Chandan Parekh has expertise in General Business.
Sanjay Chandan Parekh has 29 years in corporate governance.